221 related articles for article (PubMed ID: 25261293)
1. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
Liu Y; Colditz GA; Gehlert S; Goodman M
Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
[TBL] [Abstract][Full Text] [Related]
2. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
Liu Y; West R; Weber JD; Colditz GA
Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
[TBL] [Abstract][Full Text] [Related]
3. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Narod SA; Iqbal J; Giannakeas V; Sopik V; Sun P
JAMA Oncol; 2015 Oct; 1(7):888-96. PubMed ID: 26291673
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
5. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.
Madubata CC; Liu Y; Goodman MS; Yun S; Yu J; Lian M; Colditz GA
Breast Cancer Res Treat; 2016 Dec; 160(3):563-572. PubMed ID: 27771840
[TBL] [Abstract][Full Text] [Related]
6. Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.
Dania V; Liu Y; Ademuyiwa F; Weber JD; Colditz GA
Breast Cancer Res; 2019 Nov; 21(1):120. PubMed ID: 31727116
[TBL] [Abstract][Full Text] [Related]
7. Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors.
Liu Y; Schloemann DT; Lian M; Colditz GA
Breast Cancer Res Treat; 2015 May; 151(1):199-208. PubMed ID: 25893591
[TBL] [Abstract][Full Text] [Related]
8. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.
Innos K; Horn-Ross PL
Cancer; 2003 Feb; 97(4):1099-106. PubMed ID: 12569612
[TBL] [Abstract][Full Text] [Related]
9. Association of a Diagnosis of Ductal Carcinoma In Situ With Death From Breast Cancer.
Giannakeas V; Sopik V; Narod SA
JAMA Netw Open; 2020 Sep; 3(9):e2017124. PubMed ID: 32936299
[TBL] [Abstract][Full Text] [Related]
10. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
Berkman A; F Cole B; Ades PA; Dickey S; Higgins ST; Trentham-Dietz A; Sprague BL; Lakoski SG
Breast Cancer Res Treat; 2014 Nov; 148(2):407-13. PubMed ID: 25326349
[TBL] [Abstract][Full Text] [Related]
12. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.
Bailes AA; Kuerer HM; Lari SA; Jones LA; Brewster AM
Cancer; 2013 Jan; 119(1):150-7. PubMed ID: 22736444
[TBL] [Abstract][Full Text] [Related]
13. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.
Taparra K; Fukui J; Killeen J; Sumida K; Loo LWM; Hernandez BY
JAMA Netw Open; 2021 Oct; 4(10):e2128977. PubMed ID: 34668945
[TBL] [Abstract][Full Text] [Related]
14. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
[TBL] [Abstract][Full Text] [Related]
15. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma.
Fisher ER; Dignam J; Tan-Chiu E; Costantino J; Fisher B; Paik S; Wolmark N
Cancer; 1999 Aug; 86(3):429-38. PubMed ID: 10430251
[TBL] [Abstract][Full Text] [Related]
16. Do breast quadrants explain racial disparities in breast cancer outcomes?
Han Y; Moore JX; Langston M; Fuzzell L; Khan S; Lewis MW; Colditz GA; Liu Y
Cancer Causes Control; 2019 Nov; 30(11):1171-1182. PubMed ID: 31456108
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Ductal Carcinoma
Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
[TBL] [Abstract][Full Text] [Related]
18. Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women.
Stark A; Stapp R; Raghunathan A; Yan X; Kirchner HL; Griggs J; Newman L; Chitale D; Dick A
Breast Cancer Res Treat; 2012 Jan; 131(2):561-70. PubMed ID: 21874310
[TBL] [Abstract][Full Text] [Related]
19. Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
Arvold ND; Punglia RS; Hughes ME; Jiang W; Edge SB; Javid SH; Laronga C; Niland JC; Theriault RL; Weeks JC; Wong YN; Lee SJ; Hassett MJ
Cancer; 2012 Dec; 118(24):6022-30. PubMed ID: 22674478
[TBL] [Abstract][Full Text] [Related]
20. Association between breast density and subsequent breast cancer following treatment for ductal carcinoma in situ.
Hwang ES; Miglioretti DL; Ballard-Barbash R; Weaver DL; Kerlikowske K;
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2587-93. PubMed ID: 18086762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
